Overexpression of facilitated glucose protein 2 in renal proximal tubules of early diabetic rats

[1]

[2]

YU Yuan, HU Yiqiong, XIANG Qingwei. miR-218-5p alleviates high glucose-induced injury in mouse podocyte MPC5 [J]. Basic & Clinical Medicine, 2026, 46(2): 170-176.

[3]

CHE Yanfei, QIN Dongshan, YU Ziman, WANG Haoyu, YANG Dan, LIANG Xiaochun. Regulatory effects of Jinmaitong on high glucose-induced glycolytic reprogramming in RSC96 cells and polarization of RAW264.7 cells [J]. Basic & Clinical Medicine, 2026, 46(2): 208-214.

[4]

HE Ke, YANG Fan, LU Xiwan, HU Yun. Variations in GLP-1R rs2268641 increase risk of diabetic nephropathy in China [J]. Basic & Clinical Medicine, 2025, 45(9): 1190-1194.

[5]

[6]

[7]

ZHAO Qingqing, CHENG Xiaoliang. Research progress on biomarkers of diabetic nephropathy [J]. Basic & Clinical Medicine, 2025, 45(4): 546-550.

[8]

DENG Jie, WEI Jiali. Role of hyperuricemia in diabetic nephropathy [J]. Basic & Clinical Medicine, 2025, 45(3): 378-381.

[9]

LI Yaoyang, WANG Shuyu, YANG Dan, WU Qunli. Professor LIANG Xiaochun′s experience in the treatment of diabetic kidney disease [J]. Basic & Clinical Medicine, 2024, 44(9): 1335-1340.

[10]

OUYANG Bilu, WANG Guoqiang, WANG Mengmeng, WANG Xiuge. Development of a clinical prediction model for diabetic peripheral neuropathy with type 2 diabetes mellitus [J]. Basic & Clinical Medicine, 2024, 44(12): 1685-1690.

[11]

[12]

[13]

LIU Chong, LIU Yingying, GUO Zhaoan. Progress of specialized pro-resolving mediators in diabetic kidney disease [J]. Basic & Clinical Medicine, 2023, 43(7): 1152-1156.

[14]

ZHOU Yue, LIN Jingna. miR-199-3p inhibits diabetes retinopathy in rats by targeting at VegfA [J]. Basic & Clinical Medicine, 2023, 43(7): 1084-1089.

[15]

YU Zhuoying, YANG Jing, JIANG Ye, LI Min. Clinical advances in painful and painless diabetic neuropathy [J]. Basic & Clinical Medicine, 2023, 43(6): 985-989.

PDF